News

Marplan is a monoamine oxidase inhibitor (MAOI), a class of antidepressants usually used as a last resort treatment due to its side effects and drug interactions. Validus said

The vaccine, which was developed by Memorial Sloan-Kettering Cancer Center scientists, consists of DNA encoding a form of the tyrosinase protein. This protein is found broadly in melanoma

Avienca said that the compound has shown neuroprotective effects that may potentially slow the progression of this neurodegenerative disease. Avicena’s phase I study is an open-label, single-center, dose

Eisai filed the infringement actions in November 2003 contesting Teva and Dr Reddy’s Laboratories’ submissions of abbreviated new drug applications to the FDA for the drug. In October

The all-cash transaction has been approved by both boards, and subject to closing conditions, is expected to close in the second half of 2007. Mylan said that the

Researchers found that giving patients at least 600mg of Bristol-Myers Squibb’s Plavix (clopidogrel) before the procedure, rather than the standard 300mg dose, halved the risk of major complications

Calando is performing toxicity studies in rats and monkeys in preparation for the filing of an investigational new drug application with the FDA. Upon FDA approval, Calando plans

The FDA cannot give final approval until a dispute with Janssen, the new drug application (NDA) holder, Synaptech, the patent owner, and Barr is resolved. In June 2005,

The trial will be conducted in the Boland-Overberg region of Western Cape Province in South Africa, which has one of the world’s highest TB burdens. The study is